5 active not recruiting. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Active not recruiting 5 |
Follow Bronchitis: new trials by email Literature Review of Bronchitis trials Research Report on Bronchitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy INCA034176, Best Available Therapy (BAT) - Chronic Graft-versus-host-disease | Phase 3 | Active not recruiting | Incyte Corporation | 9 | 2025-06-04 | 2026-08-25 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease INCA034176 - Chronic Graft-versus-host-disease | Phase 3 | Active not recruiting | Incyte Biosciences Japan GK | 21 | 2024-07-30 | 2026-10-05 |
| A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. Belumosudil, Placebo, Prednisone - Chronic Graft Versus Host Disease | Phase 3 | Active not recruiting | Sanofi | 260 | 2024-01-23 | 2026-10-16 |
| Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts Extracorporeal Photopheresis (ECP), No intervention in the SOC / Retrospective Chart review. - Bronchiolitis Obliterans Syndrome (BOS) | Phase 3 | Active not recruiting | Washington University School of Medicine | 280 | 2015-01-01 | 2026-04-06 |
| A Long-term Extension Study of PCI-32765 (Ibrutinib) Ibrutinib - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 3 | Active not recruiting | Janssen Research & Development, LLC | 539 | 2013-09-09 | 2026-10-01 |
Bronchiolitis Obliterans Syndrome (5) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Waldenstrom Macroglobulinemia (1)
Bronchial Diseases (5) · Bronchiolitis (5) · Bronchiolitis Obliterans (5) · Graft vs Host Disease (5) · Immune System Diseases (5) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Organizing Pneumonia (5) · Respiratory Tract Diseases (5) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1)
Photopheresis (2) · axatilimab (2) · ibrutinib (2) · Calcineurin Inhibitors (1) · Cyclosporine (1) · Everolimus (1) · Imatinib Mesylate (1) · KD025 (1) · Mycophenolic Acid (1) · Pentostatin (1) · Prednisolone (1) · Prednisone (1) · Proteasome Inhibitors (1) · Rituximab (1) · Sirolimus (1)
Incyte Biosciences Japan GK (1) · Incyte Corporation (1) · Janssen Research & Development, LLC (1) · Sanofi (1) · Washington University School of Medicine (1)
Belgium (3) · Czechia (3) · France (3) · Germany (3) · Greece (3) · Italy (3) · Netherlands (3) · Portugal (3) · Spain (3) · Sweden (3) · United Kingdom (3) · United States (3) · Argentina (2) · Australia (2) · Austria (2)
2023 (1)